

MarketFoolery
The Motley Fool
The Motley Fool's daily look at stocks in the news, the top business/investing stories, and occasional tangents.
Episodes
Mentioned books

Jul 2, 2019 • 19min
Class Action Lawsuit. Now What?
What happens when a company you own stock in is hit with a class action lawsuit? We dip into the Fool Mailbag with MFAM Funds portfolio manager Bill Barker to discuss that topic, as well as P/E multiples and the latest surprising health study about coffee.

Jul 1, 2019 • 16min
Mid-Year Checklist for Investors
Time to rebalance? Is cash building up in your portfolio? Ron Gross shares some tips for investors doing a mid-year review of their stock holdings. Plus, we dip into the Fool Mailbag to discuss the prospects of profit-taking, as well as where investors can find good research.

Jun 27, 2019 • 20min
The Immortal Howard Hughes
Rite Aid is hanging on for dear life after a 1st-quarter loss, while McCormick rises after raising earnings guidance. MFAM Funds portfolio manager Bill Barker analyzes those stories and shares key takeaways for investors. Plus, shares of Howard Hughes Corp. rise more than 30% after the company hires bankers to explore “strategic alternatives”. We discuss the potential outcomes and the life of Howard Hughes.

Jun 26, 2019 • 15min
General Mills’ Unhealthy Returns
General Mills slips on weakness in its snacks business. FedEx warns that trade disputes and an economic slowdown have created “significant uncertainty” for FedEx Express. And Netflix announces that The Office is leaving in 2021. Motley Fool analyst Ron Gross digs into those stories and weighs in on underrated and overrated cereals. Thanks NetSuite. Get the FREE guide, “7 Key Strategies to Grow your Profits” at www.NetSuite.com/Fool.

Jun 25, 2019 • 18min
5 Summer Vacation Stocks
AbbVie buys Allergan for $63 billion in cash and stock. Jason Moser analyzes the pros and cons of the deal. Warren Buffett denies any tension between Berkshire-Hathaway and 3G Capital but, would anyone blame him if there was tension? Plus, Jason shares highlights from his trip to Costa Rica and five stock ideas the trip inspired.

Jun 24, 2019 • 21min
New King of Las Vega$
Eldorado buys Caesars Entertainment to create the largest owner & operator of casinos in the U.S. Dan Kline analyzes the hidden value in the deal and why he believes it will pay off down the line. Plus, we discuss the current state of the burger industry and the “disappointing” weekend at the box office for Toy Story 4. Thanks Netsuite. Get the FREE guide, “7 Key Strategies to Grow your Profits” at www.NetSuite.com/Fool.

Jun 20, 2019 • 25min
Wall Street Gets Some Slack
Slack makes its debut as a public company. Will the cloud-based collaboration platform make it rain for investors? Analysts Andy Cross and Ron Gross tackle that question and discuss interest rates, Olive Garden, and the future of Google. Thanks to NetSuite. Download their FREE guide, “Seven Key Strategies to Grow your Profits,” today at www.NetSuite.com/Fool.

Jun 19, 2019 • 20min
Drama in the Toy Industry
Adobe’s 2nd-quarter revenue rose 25% sending shares higher. Winnebago’s 3rd-quarter report showed improving margins. MFAM Funds portfolio manager Bill Barker analyzes those stories as well as the on-again-off-again deal between Mattel and MGA Entertainment. Plus, we look forward to this weekend’s opening of “Toy Story 4.” Thanks to Sprout Social for supporting Motley Fool. To learn how your brand can create real connection, visit sproutsocial.com/fool today.

Jun 18, 2019 • 21min
Facebook Launches Zuck Bucks
Facebook unveils its new digital currency. Sotheby’s goes private. And a new bill on Capitol Hill aims to level the playing field for investors. Bill Mann analyzes those stories, as well as the latest food business in Germany and a surprising liquor story from Canada. Thanks to NetSuite. Download their FREE guide, “Seven Key Strategies to Grow your Profits” today at www.NetSuite.com/Fool.

Jun 17, 2019 • 16min
Big Pharma’s Latest Buy
Pfizer buys Array Biopharma for $11.4 billion, sending shares of Array up 57%. Ron Gross analyzes the acquisition spree among big pharmaceutical companies. Target has a massive outage over the weekend, but we still have a few more questions about why. Plus, we dip into the Fool Mailbag and discuss the latest news from Papa John’s. Thanks to Sprout Social for supporting Motley Fool. To learn how your brand can create real connection, visit sproutsocial.com/fool today.


